Hybrid Magnetic Lipid-Based Nanoparticles for Cancer Therapy
Pharmaceutics · 23.02.2023 · 15 (3) · 751
DOI: 10.3390/pharmaceutics15030751 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 23.02.2023. Verfasst von Marcela Tavares Luiz und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-903, SP, Brazil. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, Fundação de Amparo a Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Cancer is one of the major public health problems worldwide. Despite the advances in cancer therapy, it remains a challenge due to the low specificity of treatment and the development of multidrug resistance mechanisms. To overcome these drawbacks, several drug delivery nanosystems have been investigated, among them, magnetic nanoparticles (MNP), especially superparamagnetic iron oxide nanoparticles (SPION), which have been applied for treating cancer. MNPs have the ability to be guided to the tumor microenvironment through an external applied magnetic field. Furthermore, in the presence of an alternating magnetic field (AMF) this nanocarrier can transform electromagnetic energy in heat (above 42 °C) through Néel and Brown relaxation, which makes it applicable for hyperthermia treatment. However, the low chemical and physical stability of MNPs makes their coating necessary. Thus, lipid-based nanoparticles, especially liposomes, have been used to encapsulate MNPs to improve their stability and enable their use as a cancer treatment. This review addresses the main features that make MNPs applicable for treating cancer and the most recent research in the nanomedicine field using hybrid magnetic lipid-based nanoparticles for this purpose.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-903, SP, Brazil.
- Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
ORCID-Profile: Juliana Santos Rosa Viegas, Alberto Gomes Tavares Junior, Marlus Chorilli
Förderung
- São Paulo Research Foundation
- Fundação de Amparo a Pesquisa do Estado de São Paulo
Zitieren
APA
Luiz, M. T., Dutra, J. A. P., Viegas, J. S. R., de Araújo, J. T. C., Tavares Junior, A. G., & Chorilli, M. (2023). Hybrid Magnetic Lipid-Based Nanoparticles for Cancer Therapy. Pharmaceutics, 15(3), 751. https://doi.org/10.3390/pharmaceutics15030751
Vancouver
Luiz MT, Dutra JAP, Viegas JSR, de Araújo JTC, Tavares Junior AG, Chorilli M. Hybrid Magnetic Lipid-Based Nanoparticles for Cancer Therapy. Pharmaceutics. 2023;15(3):751. doi:10.3390/pharmaceutics15030751
BibTeX
@article{Luiz2023,
author = {Luiz, Marcela Tavares and Dutra, Jessyca Aparecida Paes and Viegas, Juliana Santos Rosa and de Araújo, Jennifer Thayanne Cavalcante and Tavares Junior, Alberto Gomes and Chorilli, Marlus},
title = {Hybrid Magnetic Lipid-Based Nanoparticles for Cancer Therapy},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {3},
pages = {751},
doi = {10.3390/pharmaceutics15030751}
}
EUVIMED